Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Optimistic Surge in Pet Ownership
    3. Market Restraints
      1. High Cost and Complexity of Development and Production
      2. Stringent Regulatory Frameworks and Approval Processes
    4. Market Opportunity
      1. Integration of Digital Technologies in Veterinary Health Landscape
    5. Market Trends
      1. Rise of Personalized Veterinary Medicine
      2. Expansion of Preventive Healthcare Programs
  5. MARKET SEGMENTATION
    1. By Product
      1. Vaccines
      2. Bacterial Extracts
      3. Monoclonal Antibody
      4. Immunomodulatory
        1. Cytokines
        2. Others
      5. Allergenic Extracts
    2. By Animal
      1. Companion Animals
        1. Canine
        2. Avian
        3. Feline
      2. Livestock
        1. Aquatic
        2. Bovine
        3. Porcine
        4. Ovine/Caprine
        5. Poultry
      3. Equine
    3. By Distribution Channel
      1. Veterinary Clinics
      2. Veterinary Hospitals
      3. Veterinary Research Institutes
      4. Retail Pharmacies
    4. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. Addison Biological Laboratory Inc.
      2. American Animal Health Inc.
      3. Boehringer Ingelheim
      4. Bimeda Inc. (Texas Vet Lab Inc.)
      5. Colorado Serum Company
      6. Ceva
      7. Elanco Animal Health
      8. Hester Biosciences Limited
      9. HIPRA
      10. Merck & Co. Inc.
      11. Phibro Animal Health Corporation
      12. Virbac
      13. Zoetis Inc.

7. MARKET OPPORTUNITIES AND FUTURE TRENDS



Frequently Asked Questions

Q.1. What is the projected market value of the global Veterinary Biologics market?

The global market of veterinary biologicsis projected to reach USD 22,772.71 Mn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Veterinary Biologics market?

The global veterinary biologicsmarket has an estimated annual growth rate of 6.3%.

Q.3. What are the recent trends of Veterinary Biologics market?

Rise of personalized veterinary medicine and expansion of preventive healthcare programs are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Veterinary Biologics?

The major companies profiled in this report include Addison Biological Laboratory Inc., American Animal Health Inc., Boehringer Ingelheim, Bimeda Inc. (Texas Vet Lab Inc.), Colorado Serum Company, Ceva, Elanco Animal Health, Hester Biosciences Limited, HIPRA, Merck & Co. Inc., Phibro Animal Health Corporation, Virbac, among others.

Q.5. Which is the largest regional market in the Veterinary Biologics?

North America is the largest regional market for Veterinary Biologics.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.